B CELL LYMPHOMA
Clinical trials for B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study is testing an oral drug called LOXO-338 in people with advanced blood cancers (like certain leukemias, lymphomas, and multiple myeloma) who have already received standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumo…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 05:16 UTC
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC
-
Blood cancer drug Pirtobrutinib's Long-Term safety under review
Disease control OngoingThis study looks at the long-term safety of the drug pirtobrutinib in people with certain blood cancers, like chronic lymphocytic leukemia or non-Hodgkin lymphoma. It includes 13 participants who already completed an earlier study and are still benefiting from the treatment. They…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC